OverviewChartNewsTraderScreen

Alector/  US0144421072  /

IEX
9/13/2024  9:59:56 PM Chg. +0.42 Volume Bid- Ask- High Low
6.04USD +7.47% 31,576
Turnover: 185,931		 -Bid Size: - -Ask Size: - 6.07 5.74
GlobeNewswire 8/29 Alector to Participate in Upcoming Healthcare Conferences
GlobeNewswire 8/8 Aligos Therapeutics Strengthens Board with Two New Independent Directors
GlobeNewswire 8/7 Alector Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 7/31 Alector to Host Mid-Year Earnings Conference Call
GlobeNewswire 7/28 Alector Presents Baseline Characteristics for INVOKE-2 Phase 2 Clinical Trial of AL002 at the Alzhei...
GlobeNewswire 7/23 Alector to Present Data on Pipeline Focus Areas at the Alzheimer's Association International Confere...
GlobeNewswire 6/20 Alector to Participate in the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference
GlobeNewswire 6/10 Alector to Host Virtual Research and Development Event Highlighting Alector Brain Carrier Blood-Brai...
GlobeNewswire 6/3 Alector to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire 5/14 Tenaya Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 5/9 Alector to Participate in Upcoming Healthcare Conferences
GlobeNewswire 5/8 Alector Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 2/28 Alector to Participate in Upcoming Healthcare Conferences
GlobeNewswire 2/27 Alector Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
GlobeNewswire 2/20 Alector to Host Fourth Quarter and Full-Year 2023 Earnings Call
GlobeNewswire 2/8 Alector Announces First Patient Dosed in PROGRESS-AD Phase 2 Clinical Trial of AL101/GSK4527226 in P...
GlobeNewswire 1/19 Alector Announces Closing of Public Offering
GlobeNewswire 1/16 Alector Announces Proposed Public Offering of Common Stock
GlobeNewswire 12/13/2023 CENTOGENE’s Frontotemporal Dementia (FTD) Genetic Study, EFRONT, Reaches Initial Patient Enrollment ...
GlobeNewswire 12/12/2023 Vanqua Bio Advances Clinical Candidate for Parkinson’s Disease, Expands Leadership Team to Support F...
GlobeNewswire 11/28/2023 Alector to Host Two Virtual Research and Development Events Highlighting TREM2 and Progranulin Progr...
GlobeNewswire 11/8/2023 Alector to Participate in the Stifel Healthcare Conference
GlobeNewswire 11/7/2023 Alector Reports Third Quarter 2023 Financial Results and Provides Business Update
GlobeNewswire 10/27/2023 Alector Announces Achievement of Target Enrollment in the Pivotal INFRONT-3 Phase 3 Clinical Trial o...
GlobeNewswire 9/7/2023 Alector Announces Completion of Enrollment in the INVOKE-2 Phase 2 Clinical Trial of AL002, a TREM2 ...